What is the Hemoglobin A1c (HbA1c) level for prediabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HbA1c Range for Prediabetes

The HbA1c range for prediabetes is 5.7% to 6.4% (39 to 46 mmol/mol) according to the American Diabetes Association guidelines. 1

Definition and Diagnostic Criteria

Prediabetes represents an intermediate stage between normal glucose regulation and diabetes, characterized by:

  • HbA1c levels of 5.7% to 6.4% (39 to 46 mmol/mol) 1
  • Fasting plasma glucose (FPG) of 100 mg/dL to 125 mg/dL (5.6 to 6.9 mmol/L), also known as impaired fasting glucose (IFG) 1
  • 2-hour plasma glucose during 75-g oral glucose tolerance test (OGTT) of 140 mg/dL to 199 mg/dL (7.8 to 11.0 mmol/L), also known as impaired glucose tolerance (IGT) 1

Risk Stratification Within Prediabetes

The risk of progression to diabetes is not uniform across the prediabetes HbA1c range:

  • HbA1c 5.7% to 6.0% (39 to 42 mmol/mol): 5-year risk of developing diabetes ranges from 9% to 25% 1
  • HbA1c 6.0% to 6.4% (42 to 46 mmol/mol): 5-year risk increases to 25% to 50%, with a relative risk approximately 20 times higher compared to those with HbA1c of 5.0% 1

Clinical Implications and Risk Assessment

  • Baseline HbA1c is a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose in community-based studies 1
  • Risk of progression to diabetes follows HbA1c levels as a continuum, with higher values associated with disproportionately greater risk 1
  • Approximately 10% of people with prediabetes progress to diabetes each year in the US 2
  • Individuals with both elevated HbA1c (5.7-6.4%) and impaired fasting glucose have substantially higher risk of progression to diabetes than those with either criterion alone 3

Important Clinical Considerations

  • The risk for developing diabetes follows HbA1c as a continuum, becoming disproportionately greater at the higher end of the prediabetes range 1
  • More intensive follow-up and interventions should be considered for those with HbA1c levels above 6.0%, who are at very high risk 1
  • Some research suggests that an HbA1c cutoff point of 5.9% may better identify individuals at high risk of progression to diabetes than the 5.7% value in certain populations 4
  • The positive predictive value of HbA1c for diagnosis of prediabetes in clinical practice may be limited, with some studies showing values as low as 39.4% 5

Screening Recommendations

  • Testing for prediabetes should be considered in adults who are overweight or obese (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans) with one or more additional risk factors 1
  • For all people without risk factors, testing should begin at age 45 years 1
  • If tests are normal, repeat testing at minimum 3-year intervals is reasonable 1

Prevention Strategies

  • Individuals with HbA1c of 5.7-6.4% should be informed of their increased risk for diabetes and cardiovascular disease 1
  • Lifestyle modification (calorie restriction, increased physical activity ≥150 min/week) has been shown to decrease the incidence of diabetes by 6.2 cases per 100 person-years over a 3-year period 2
  • Metformin may be particularly effective for women with prior gestational diabetes and individuals younger than 60 years with BMI ≥35, fasting plasma glucose ≥110 mg/dL, or HbA1c ≥6.0% 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.